A new phase one clinical trial has started in the United States to evaluate Moderna’s investigational vaccine which is designed to protect against the B.1.351 coronavirus variant, the US National …, A new phase one clinical trial has started in the United States to evaluate Moderna’s investigational vaccine which is designed to protect against the B.1.351 coronavirus variant, the US National …, Read More